| List Name |
Annotation |
Enrichment |
p-value |
| protein processing |
AmiGO Browser |
7.10 |
2.59e-03 |
| mammary gland development |
AmiGO Browser |
22.47 |
3.55e-03 |
| multicellular organismal development |
AmiGO Browser |
1.73 |
6.11e-03 |
| gland development |
AmiGO Browser |
7.49 |
7.74e-03 |
| developmental process |
AmiGO Browser |
1.57 |
9.32e-03 |
| regulation of growth |
AmiGO Browser |
3.86 |
0.01 |
| tube morphogenesis |
AmiGO Browser |
6.07 |
0.01 |
| growth |
AmiGO Browser |
3.01 |
0.02 |
| pattern specification process |
AmiGO Browser |
3.71 |
0.02 |
| sterol biosynthetic process |
AmiGO Browser |
8.26 |
0.02 |
| anatomical structure development |
AmiGO Browser |
1.57 |
0.03 |
| response to drug |
AmiGO Browser |
7.10 |
0.03 |
| actin filament organization |
AmiGO Browser |
6.74 |
0.04 |
| protein amino acid autophosphorylation |
AmiGO Browser |
6.32 |
0.04 |
| tube development |
AmiGO Browser |
3.99 |
0.04 |
| regionalization |
AmiGO Browser |
3.97 |
0.04 |
| branching morphogenesis of a tube |
AmiGO Browser |
6.22 |
0.04 |
| morphogenesis of a branching structure |
AmiGO Browser |
6.13 |
0.04 |
| Notch signaling pathway |
AmiGO Browser |
6.13 |
0.04 |
| protein autoprocessing |
AmiGO Browser |
6.04 |
0.04 |
| multicellular organismal process |
AmiGO Browser |
1.40 |
0.04 |
| regulation of smooth muscle cell proliferation |
AmiGO Browser |
20.23 |
0.05 |
| microtubule bundle formation |
AmiGO Browser |
20.23 |
0.05 |
| hemoglobin metabolic process |
AmiGO Browser |
20.23 |
0.05 |
| regulation of smoothened signaling pathway |
AmiGO Browser |
20.23 |
0.05 |
| embryonic development |
AmiGO Browser |
2.55 |
0.05 |
| cell growth |
AmiGO Browser |
2.91 |
0.05 |
| system development |
AmiGO Browser |
1.54 |
0.05 |
| embryonic appendage morphogenesis |
AmiGO Browser |
5.54 |
0.05 |
| embryonic limb morphogenesis |
AmiGO Browser |
5.54 |
0.05 |
| regulation of cell size |
AmiGO Browser |
2.87 |
0.05 |
| smooth muscle cell proliferation |
AmiGO Browser |
18.39 |
0.05 |
| male sex determination |
AmiGO Browser |
18.39 |
0.05 |
| oligopeptide transport |
AmiGO Browser |
18.39 |
0.05 |
| limb morphogenesis |
AmiGO Browser |
5.32 |
0.05 |
| appendage morphogenesis |
AmiGO Browser |
5.32 |
0.05 |
| appendage development |
AmiGO Browser |
5.32 |
0.05 |
| muscle cell proliferation |
AmiGO Browser |
15.56 |
0.06 |
| insulin-like growth factor receptor signaling pathway |
AmiGO Browser |
15.56 |
0.06 |
| cytoplasmic sequestering of transcription factor |
AmiGO Browser |
15.56 |
0.06 |
| cytoplasmic sequestering of protein |
AmiGO Browser |
15.56 |
0.06 |
| chromatin remodeling |
AmiGO Browser |
4.82 |
0.07 |
| organ morphogenesis |
AmiGO Browser |
2.13 |
0.07 |
| transmembrane receptor protein tyrosine kinase signaling pathway |
AmiGO Browser |
2.64 |
0.07 |
| neuromuscular synaptic transmission |
AmiGO Browser |
14.45 |
0.07 |
| negative regulation of caspase activity |
AmiGO Browser |
14.45 |
0.07 |
| thyroid hormone metabolic process |
AmiGO Browser |
14.45 |
0.07 |
| enzyme linked receptor protein signaling pathway |
AmiGO Browser |
2.31 |
0.07 |
| isoprenoid biosynthetic process |
AmiGO Browser |
13.48 |
0.07 |
| cGMP biosynthetic process |
AmiGO Browser |
13.48 |
0.07 |
| heterochromatin formation |
AmiGO Browser |
13.48 |
0.07 |
| chromatin silencing |
AmiGO Browser |
13.48 |
0.07 |
| negative regulation of transcription factor import into nucleus |
AmiGO Browser |
12.64 |
0.08 |
| negative regulation of protein import into nucleus |
AmiGO Browser |
12.64 |
0.08 |
| post-translational protein modification |
AmiGO Browser |
1.54 |
0.08 |
| nervous system development |
AmiGO Browser |
1.74 |
0.08 |
| cell maturation |
AmiGO Browser |
4.30 |
0.08 |
| specification of organ identity |
AmiGO Browser |
11.90 |
0.08 |
| cell-cell signaling during cell fate commitment |
AmiGO Browser |
11.90 |
0.08 |
| induction of an organ |
AmiGO Browser |
11.90 |
0.08 |
| induction |
AmiGO Browser |
11.90 |
0.08 |
| negative regulation of protein transport |
AmiGO Browser |
11.90 |
0.08 |
| positive regulation of cell migration |
AmiGO Browser |
11.90 |
0.08 |
| negative regulation of nucleocytoplasmic transport |
AmiGO Browser |
11.90 |
0.08 |
| regulation of cell growth |
AmiGO Browser |
2.93 |
0.08 |
| water transport |
AmiGO Browser |
11.24 |
0.09 |
| patterning of blood vessels |
AmiGO Browser |
11.24 |
0.09 |
| endothelial cell differentiation |
AmiGO Browser |
11.24 |
0.09 |
| fluid transport |
AmiGO Browser |
11.24 |
0.09 |
| steroid biosynthetic process |
AmiGO Browser |
4.09 |
0.09 |
| negative regulation of gene expression, epigenetic |
AmiGO Browser |
10.65 |
0.09 |
| dicarboxylic acid transport |
AmiGO Browser |
10.65 |
0.09 |
| cartilage condensation |
AmiGO Browser |
10.11 |
0.09 |
| purine nucleoside monophosphate metabolic process |
AmiGO Browser |
10.11 |
0.09 |
| purine nucleoside monophosphate biosynthetic process |
AmiGO Browser |
10.11 |
0.09 |
| purine ribonucleoside monophosphate metabolic process |
AmiGO Browser |
10.11 |
0.09 |
| purine ribonucleoside monophosphate biosynthetic process |
AmiGO Browser |
10.11 |
0.09 |
| male gamete generation |
AmiGO Browser |
2.70 |
0.10 |
| spermatogenesis |
AmiGO Browser |
2.70 |
0.10 |
| cGMP metabolic process |
AmiGO Browser |
9.19 |
0.10 |
| smoothened signaling pathway |
AmiGO Browser |
9.19 |
0.10 |
| cell fate commitment |
AmiGO Browser |
3.64 |
0.10 |
L2L Microarray Analysis Tool